|
Baseline demographic and clinical characteristics of all randomized patients. |
||||
| Demographic characteristics |
TRT GR A |
TRT GR B |
TRT GR C |
TRT GR D |
|
|
||||
| Mean age(SD) |
53.2(6.0) |
51.0(7.3) |
54.1(5.8) |
52.5(7.1) |
| Age range(yr) |
36–61 |
34–59 |
34–60 |
35–62 |
| Sex |
||||
| Female |
14 |
15 |
15 |
16 |
| Male |
7 |
6 |
6 |
5 |
| Race (%Black) |
100.0 |
100.0 |
100.0 |
100.0 |
| Ethnic origin(% Yoruba) |
100.0 |
100.0 |
100.0 |
100.0 |
| Religion(%Christianity) |
80.9 |
76.2 |
90.4 |
80.9 |
| Knee most affected |
||||
| Right |
8 |
7 |
8 |
6 |
| Left |
6 |
6 |
4 |
8 |
| Bilateral |
7 |
8 |
9 |
7 |
|
|
||||
| Clinical characteristics |
||||
|
|
||||
| KOA mean aduration(yr) |
9.2(7.5) |
11.1(8.0) |
9.9(10.6) |
8.8(9.3) |
| Hypertension mean duration (yr) |
7.0(5.6) |
5.8(6.7) |
6.1(5.3) |
6.5(5.8) |
| N = 5 |
N = 6 |
N = 6 |
N = 5 |
|
| Mean SBP(mm Hg) |
132(14.7) |
136(19.1) |
136(17.8) |
138(16.9) |
| Mean DBP(mm Hg) |
84(19.4) |
88(18.9) |
87(18.5) |
86(17.0) |
| Mean Weight(kg) |
71(18.2) |
74(23.1) |
73(17.5) |
72(19.4) |
| Cardiovascular history |
NAD |
NAD |
NAD |
NAD |
| Anti-hypertensive medication |
Nifedipine |
Nifedipine |
Nifedipine |
Nifedipine |
| Mean BMI |
28(9.2) |
27(10.1) |
27(10.3) |
28(8.9) |
|
N.B: TRT = Treatment GRP A = Placebo Control GRP B = Naproxen GRP C = Garcinia kola GRP D = Celebrex | ||||
Adegbehingbe et al. Journal of Orthopaedic Surgery and Research 2008 3:34 doi:10.1186/1749-799X-3-34 |
||||